Listed

Indaptus Therapeutics, Inc.

INDPNasdaqCIK 1857044HealthcareFiscal year ends Dec 31

Reports and events: 138 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Indaptus Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2025-07-0108:38 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-017283
2025-06-2617:15 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001641172-25-016694
2025-06-2316:37 ETDEF 14AProxy statementPeriod 2025-06-230001641172-25-016071
2025-06-1308:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001641172-25-014972
2025-06-1116:01 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001641172-25-014689
2025-05-1408:01 ET10-QQuarterly reportPeriod 2025-03-310001641172-25-010099
2025-05-1408:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001641172-25-010098
2025-04-2816:15 ETDEF 14AProxy statementPeriod 2025-04-280001641172-25-006429
2025-03-1307:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-25-010138
2025-03-1307:30 ET10-KAnnual reportPeriod 2024-12-310001493152-25-010136
2025-02-1211:38 ETS-1Registration statement0001493152-25-006068
2025-02-1209:22 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-25-006052
2025-01-3116:15 ET8-K3.01 Delisting notice0001493152-25-004428
2025-01-1416:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-25-002145
2024-12-2316:52 ETS-1Registration statement0001493152-24-051850
2024-11-2616:11 ETSC 13D/AOwnership report, active investor, amended0001493152-24-047805
2024-11-2216:48 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-047422
2024-11-1208:05 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-044537
2024-11-1208:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-044533
2024-10-2208:05 ET8-K8.01 Other events0001493152-24-041886
2024-10-1016:10 ETSC 13DOwnership report, active investor0001493152-24-040734
2024-09-1216:45 ETS-1Registration statement0001493152-24-036059
2024-08-1208:01 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-031158
2024-08-1208:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-031157
2024-08-0808:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-24-030671
2024-06-0716:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-24-023119
2024-05-2208:00 ET8-K8.01 Other events0001493152-24-020966
2024-05-0808:06 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018162
2024-05-0808:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-018161
2024-04-2609:00 ETDEF 14AProxy statementPeriod 2024-04-260001493152-24-016072
2024-03-2508:31 ET8-K8.01 Other events0001493152-24-011080
2024-03-1308:02 ET10-KAnnual reportPeriod 2023-12-310001493152-24-009769
2024-03-1308:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-24-009766
2024-03-0411:01 ET8-K8.01 Other events0001493152-24-008670
2024-01-2316:05 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-24-003441
2023-11-0616:06 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-039523
2023-11-0616:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-039517
2023-11-0608:13 ET8-K8.01 Other events0001493152-23-039445
2023-10-3109:12 ET8-K8.01 Other events0001493152-23-038800
2023-08-1408:15 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-028059
2023-08-1408:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-028054
2023-08-1008:45 ET8-K8.01 Other events0001493152-23-027463
2023-05-2516:05 ET8-K5.07 Shareholder vote results0001493152-23-019073
2023-05-1107:10 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-016268
2023-05-1107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-016267
2023-04-1208:00 ETDEF 14AProxy statementPeriod 2023-04-120001493152-23-011938
2023-03-2308:00 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001493152-23-008636
2023-03-1708:05 ET10-KAnnual reportPeriod 2022-12-310001493152-23-008010
2023-03-1708:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001493152-23-008009
2023-02-1408:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-23-004613

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:10 ET. Listed shows no prices and gives no investment advice.